These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 36606578)
1. Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer. Liu X; Zhang C; Wang X; Cui C; Cui H; Zhu B; Chen A; Zhang L; Xin J; Fu Q; Dionigi G; Sun H Endocr Relat Cancer; 2023 Mar; 30(3):. PubMed ID: 36606578 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis. Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764 [TBL] [Abstract][Full Text] [Related]
3. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p. Wang D; Zheng Y Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis. Yi D; Zhang D; He J Cell Cycle; 2021 Dec; 20(24):2619-2637. PubMed ID: 34781815 [TBL] [Abstract][Full Text] [Related]
5. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway. Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis. Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775 [TBL] [Abstract][Full Text] [Related]
7. RNF185 antisense RNA 1 (RNF185-AS1) promotes proliferation, migration, and invasion in papillary thyroid carcinoma. Liu D; Zhang M; Song Y; Yang N Anticancer Drugs; 2022 Jul; 33(6):595-606. PubMed ID: 35324519 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA AGAP2-AS1 promotes proliferation and metastasis in papillary thyroid cancer by miR-628-5p/KLF12 axis. Xu C; Shao Y; Liu J; Yao X; Quan F; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Bai Y; Zheng Z; Zhang S J Bioenerg Biomembr; 2021 Apr; 53(2):235-245. PubMed ID: 33604734 [TBL] [Abstract][Full Text] [Related]
9. lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer. Ji L; Fan X; Zhou F; Gu J; Deng X J Cell Physiol; 2020 Apr; 235(4):3669-3678. PubMed ID: 31587286 [TBL] [Abstract][Full Text] [Related]
10. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3. Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577 [TBL] [Abstract][Full Text] [Related]
11. LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis. Zhang X; Zhang X; Jia Q; Li H; Ma R; Yang G; Yin F; Jiang N; Yin D BMC Cancer; 2022 Mar; 22(1):344. PubMed ID: 35351042 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p. Chen Y; Li Y; Gao H Cancer Med; 2020 Mar; 9(5):1830-1841. PubMed ID: 31943867 [TBL] [Abstract][Full Text] [Related]
13. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer. Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634 [No Abstract] [Full Text] [Related]
15. The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression. Huang Y; Zhang K; Li Y; Dai Y; Zhao H Aging (Albany NY); 2020 Nov; 12(22):23326-23336. PubMed ID: 33197895 [TBL] [Abstract][Full Text] [Related]
16. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p. Hou S; Lin Q; Guan F; Lin C J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma. Feng Z; Chen R; Huang N; Luo C Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163 [TBL] [Abstract][Full Text] [Related]
18. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines. Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis. Wu S; Zhu J; Jiang T; Cui T; Zuo Q; Zheng G; Li G; Zhou J; Chen X Clin Epigenetics; 2024 Jan; 16(1):10. PubMed ID: 38195623 [TBL] [Abstract][Full Text] [Related]
20. LncRNA FAM230B promotes the metastasis of papillary thyroid cancer by sponging the miR-378a-3p/WNT5A axis. Zhou Q; Feng J; Yin S; Ma S; Wang J; Yi H Biochem Biophys Res Commun; 2021 Mar; 546():83-89. PubMed ID: 33578293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]